The Generator Scorecard, developed by PNNL in partnership with BPA, automates generator evaluations, reducing engineering workloads and improving grid reliability.
PNNL was well represented at the NAWEA/WindTech 2024 Conference with 13 PNNL experts at the conference sponsored by the North American Wind Energy Academy.
The Pacific Northwest Association of Toxicologists (PANWAT) presented its annual Toxicology Achievement Award to Katrina Waters at the Society of Toxicology Pacific Northwest Chapter Meeting, held in Lynnwood, Washington, on September 30th.
The National Transmission Planning Study presents several transmission expansion scenarios that would reliably support the growing demand for energy across the nation.
PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.
Early life exposure to polycyclic aromatic hydrocarbons (PAHs), found in smoke, has been linked to developmental problems. To study the impacts of these pollutants, PAH metabolism in infants and adults were compared.
Andrew White goes back to his alma mater, Georgia Tech, as young alumni keynote speaker for the Sustainability Showcase, part of the university’s larger Sustainable Development Goals Action & Awareness Week.
PNNL computing experts Robert Rallo and Court Corley contribute their knowledge to a recent DOE report on applications of AI to energy, materials, and the power grid.
There are many ways that researchers at PNNL bring unique perspectives to the field of distributed wind. One is the fact that PNNL's distributed wind projects are all led by women.
ChatGrid™ is a practical application of the Department of Energy’s exascale computing efforts and offers a new experience in easy, intuitive, and interactive data interaction.
PNNL had a significant presence at October’s North American Wind Energy Academy/WindTech 2023 Conference in Denver, Colorado. Thirteen PNNL wind experts participated in various capacities.
Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.